Furberg CD, Pitt B: Withdrawal of cerivastatin from the world market. In: Curr Control Trials Cardiovasc Med. 2. Jahrgang, Nr.5, 2001, S.205–207, PMID 11806796, PMC 59524 (freier Volltext) – (englisch, springer.com [PDF]).
Shitara Y, Hirano M, Sato H, Sugiyama Y.: Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil. In: J Pharmacol Exp Ther. 311. Jahrgang, 2004, PMID 15194707 (englisch).
